Cohen Klingenstein’s Elevance Health ELV Stock Holding History

Cohen Klingenstein’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,600	Closed	-$1.87M	–	214
2024 Q3	$1.87M	Hold	3,600	–	–	0.07%	137
2024 Q2	$1.95M	Hold	3,600	–	–	0.07%	132
2024 Q1	$1.87M	Hold	3,600	–	–	0.07%	134
2023 Q4	$1.7M	Hold	3,600	–	–	0.07%	135
2023 Q3	$1.57M	Hold	3,600	–	–	0.07%	136
2023 Q2	$1.6M	Hold	3,600	–	–	0.07%	136
2023 Q1	$1.66M	Hold	3,600	–	–	0.08%	132
2022 Q4	$1.85M	Hold	3,600	–	–	0.09%	125
2022 Q3	$1.64M	Hold	3,600	–	–	0.09%	125
2022 Q2	$1.74M	Hold	3,600	–	–	0.09%	123
2022 Q1	$1.77M	Hold	3,600	–	–	0.07%	129
2021 Q4	$1.67M	Hold	3,600	–	–	0.07%	136
2021 Q3	$1.34M	Hold	3,600	–	–	0.06%	152
2021 Q2	$1.37M	Hold	3,600	–	–	0.06%	159
2021 Q1	$1.29M	Hold	3,600	–	–	0.06%	156
2020 Q4	$1.16M	Hold	3,600	–	–	0.06%	160
2020 Q3	$967K	Hold	3,600	–	–	0.05%	167
2020 Q2	$947K	Hold	3,600	–	–	0.06%	165
2020 Q1	$817K	Hold	3,600	–	–	0.06%	164
2019 Q4	$1.09M	Hold	3,600	–	–	0.06%	154
2019 Q3	$864K	Buy	+3,600	New	+$986K	0.05%	176

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cohen Klingenstein's ELV Position: Q4 2024 in Review

Cohen Klingenstein sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 3,600 shares — an estimated $1.87M sold.

Cohen Klingenstein first reported a position in ELV in Q3 2019 and held it in 21 quarters. The position peaked at $1.95M in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Cohen Klingenstein reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Cohen Klingenstein sold 3,600 Elevance Health shares in Q4 2024, an estimated $1.87M.
Cohen Klingenstein first reported a position in Elevance Health in Q3 2019 and held it in 21 quarters.
Cohen Klingenstein's Elevance Health position peaked at $1.95M in Q2 2024.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Cohen Klingenstein's 13F filing for Q4 2024, filed 15 Jan 2025.